Barclays’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-513
| Closed | -$104K | – | 5409 |
|
|
2021
Q4 | $104K | Buy |
+513
| New | +$111K | ﹤0.01% | 3722 |
|
|
2021
Q1 | – | Sell |
-1,680
| Closed | -$428K | – | 5036 |
|
|
2020
Q4 | $428K | Buy |
1,680
+1,280
| +320% | +$331K | ﹤0.01% | 3336 |
|
|
2020
Q3 | $100K | Sell |
400
-73
| -15% | -$23K | ﹤0.01% | 4252 |
|
|
2020
Q2 | $164K | Sell |
473
-3,620
| -88% | -$1.13M | ﹤0.01% | 4212 |
|
|
2020
Q1 | $1.1M | Sell |
4,093
-5,594
| -58% | -$1.73M | ﹤0.01% | 2856 |
|
|
2019
Q4 | $3.14M | Buy |
9,687
+474
| +5% | +$137K | ﹤0.01% | 2518 |
|
|
2019
Q3 | $2.52M | Sell |
9,213
-2,407
| -21% | -$883K | ﹤0.01% | 2586 |
|
|
2019
Q2 | $6.2M | Buy |
11,620
+2,693
| +30% | +$1.35M | ﹤0.01% | 1675 |
|
|
2019
Q1 | $4.5M | Sell |
8,927
-546
| -6% | -$324K | ﹤0.01% | 1742 |
|
|
2018
Q4 | $4.67M | Sell |
9,473
-2,440
| -20% | -$1.47M | ﹤0.01% | 1649 |
|
|
2018
Q3 | $10.9M | Sell |
11,913
-5,740
| -33% | -$4.9M | 0.01% | 1211 |
|
|
2018
Q2 | $12.9M | Buy |
17,653
+12,526
| +244% | +$14.4M | 0.01% | 1057 |
|
|
2018
Q1 | $8.17M | Sell |
5,127
-2,206
| -30% | -$2.84M | 0.01% | 1300 |
|
|
2017
Q4 | $6.57M | Sell |
7,333
-314
| -4% | -$186K | 0.01% | 1460 |
|
|
2017
Q3 | $2.75M | Buy |
7,647
+1,814
| +31% | +$567K | ﹤0.01% | 2039 |
|
|
2017
Q2 | $1.71M | Sell |
5,833
-240
| -4% | -$69.4K | ﹤0.01% | 2388 |
|
|
2017
Q1 | $2.14M | Buy |
6,073
+5,966
| +5,576% | +$1.34M | ﹤0.01% | 2030 |
|
|
2016
Q4 | $20K | Sell |
107
-1,020
| -91% | -$207K | ﹤0.01% | 5618 |
|
|
2016
Q3 | $290K | Buy |
1,127
+240
| +27% | +$61.8K | ﹤0.01% | 3656 |
|
|
2016
Q2 | $189K | Buy |
887
+780
| +729% | +$174K | ﹤0.01% | 3959 |
|
|
2016
Q1 | $21K | Sell |
107
-1,306
| -92% | -$251K | ﹤0.01% | 5193 |
|
|
2015
Q4 | $339K | Buy |
1,413
+126
| +10% | +$25.9K | ﹤0.01% | 3506 |
|
|
2015
Q3 | $193K | Buy |
1,287
+1,120
| +671% | +$198K | ﹤0.01% | 4159 |
|
|
2015
Q2 | $30K | Sell |
167
-6,606
| -98% | -$1.14M | ﹤0.01% | 5442 |
|
|
2015
Q1 | $1.12M | Buy |
6,773
+6,293
| +1,311% | +$1.29M | ﹤0.01% | 2866 |
|
|
2014
Q4 | $108K | Sell |
480
-1,127
| -70% | -$241K | ﹤0.01% | 5143 |
|
|
2014
Q3 | $289K | Buy |
1,607
+387
| +32% | +$74.1K | ﹤0.01% | 4422 |
|
|
2014
Q2 | $220K | Sell |
1,220
-333
| -21% | -$58.9K | ﹤0.01% | 4727 |
|
|
2014
Q1 | $280K | Buy |
1,553
+800
| +106% | +$158K | ﹤0.01% | 4472 |
|
|
2013
Q4 | $124K | Sell |
753
-4,367
| -85% | -$704K | ﹤0.01% | 5452 |
|
|
2013
Q3 | $768K | Buy |
5,120
+3,060
| +149% | +$566K | ﹤0.01% | 3644 |
|
|
2013
Q2 | $357K | Buy |
+2,060
| New | +$316K | ﹤0.01% | 4598 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
